Multidrug resistance phenotype analysis at diagnosis
. | Without quinine . | . | With quinine . | . | Total . | . | |||
---|---|---|---|---|---|---|---|---|---|
. | N . | CR, % . | N . | CR, % . | N . | P . | |||
mdr1 gene+ | 36 | 80.0 | 40 | 87.5 | 76 | NS | |||
mdr1 gene- | 96 | 80.4 | 92 | 86.2 | 188 | NS | |||
4 E3+ | 30 | 83.3 | 32 | 87.5 | 62 | NS | |||
4 E3- | 82 | 76.8 | 87 | 75.9 | 169 | NS | |||
UIC2+ | 38 | 81.6 | 39 | 79.5 | 77 | NS | |||
UIC2- | 88 | 75.0 | 72 | 80.6 | 160 | NS | |||
Rh123 efflux+ | 25 | 48.0 | 29 | 82.8 | 54 | .01 | |||
Rh 123 efflux- | 53 | 86.8 | 53 | 77.4 | 106 | NS |
. | Without quinine . | . | With quinine . | . | Total . | . | |||
---|---|---|---|---|---|---|---|---|---|
. | N . | CR, % . | N . | CR, % . | N . | P . | |||
mdr1 gene+ | 36 | 80.0 | 40 | 87.5 | 76 | NS | |||
mdr1 gene- | 96 | 80.4 | 92 | 86.2 | 188 | NS | |||
4 E3+ | 30 | 83.3 | 32 | 87.5 | 62 | NS | |||
4 E3- | 82 | 76.8 | 87 | 75.9 | 169 | NS | |||
UIC2+ | 38 | 81.6 | 39 | 79.5 | 77 | NS | |||
UIC2- | 88 | 75.0 | 72 | 80.6 | 160 | NS | |||
Rh123 efflux+ | 25 | 48.0 | 29 | 82.8 | 54 | .01 | |||
Rh 123 efflux- | 53 | 86.8 | 53 | 77.4 | 106 | NS |
Criteria for positivity are indicated in “Patients and methods.” NS indicates not significant.